Bilirubin-induced neurologic dysfunction (BIND) attributed to excessive bilirubin production and isoimmunization is probably amenable to prevention by early identification of hemolysis and blood group incompatibilities as well as timely, effective interventions such as phototherapy [1, 2]. Nevertheless, precise intervention thresholds for the most vulnerable infants remain elusive. Clinical reliance on total serum/plasma bilirubin (TB) or levels has not yet been complemented with accurate measurements of bilirubin-binding and unbound bilirubin (UB). It is the latter that has been implicated in widespread neurological dysfunction, characterized as the syndrome of BIND [3]. Of these, disturbances of visuo-oculomotor, auditory, speech, cognition, and language among children have been proposed [3, 4]. Perturbations of infant visuocortical development, assessed by serial contrast sensitivity and vernier acuity measurements using sweep visual evoke potentials (sVEPs) have been implicated in long-term consequences of bilirubin exposure, including impaired visual acuity [4].
Here, we report that neonatal hyperbilirubinemia causes significant, long-lasting negative effects on the developing visual cortex, even at TB levels not considered harmful. We explored whether less profound but significant effects on visual acuity occurs during infancy at lower total bilirubin (as measured by TB or transcutaneous bilirubin [TcB]) levels, and whether there is an overall correlation with severity of hyperbilirubinemia. This observational study showed that BIND can affect the visual cortex with impairments failing to improve with time through the first year after birth. The methods used in this study demonstrate that BIND may be associated with long-term visual disorders, at least including a reduction in visual acuity. Other disorders of vision are possible, but require additional follow up.
We followed 89 consecutive full-term healthy infants to 12 months of age. Peak total bilirubin levels were determined by serial TB or TcB measurements and ranged from 2 to 22.9 mg/dL at admission. At 6 and 12 months of age, specific cortical function (contrast sensitivity, vernier acuity, and grating acuity) was assessed using sVEPs [4]. These 3 functions reflect the integrity of different visuocortical mechanisms. We found a significant correlation between peak total bilirubin levels and vernier acuity thresholds (see Fig. 1) and contrast thresholds, with worsening at higher levels of bilirubin. Grating acuity did not correlate with bilirubin levels. These findings were unchanged whether TB or TcB was used alone or with UB. The solid circles in the figure are children in the top quartile on the hour-specific bilirubin nomogram. Thresholds are expressed in log units on the Y-axis. Higher levels on the axis indicate worse acuity. The X-axis shows the total bilirubin (serum or, TcB) measures shortly after birth. Blue circles represent vernier thresholds at 6 months of age; red circles at 12 months of age in the same group of children. Similar findings occurred with contrast sensitivity acuity.
Importantly, these finding persisted to 12 months of age suggesting that alterations in visuocortical function endure through at least the first year after birth. The clinical significance of these findings is as yet unknown, but are concerning since these changes were observed at levels of bilirubin believed to be safe. These findings are being further investigated in an identical ongoing study in premature infants.
References
Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage. N. Engl J Med. 2015;370:979.
Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol. 1998;25:555–74, viii.
Bhutani VK, Johnson-Hamerman L. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Fetal Neonatal Med. 2015;20:6–13.
Hou C, Norcia AM, Madan A, Good WV. Visuocortical function in infants with a history of neonatal jaundice. Invest Ophthalmol Vis Sci. 2014;55:6443–9.
Funding
Funded by National institutes of Health, National Eye Institute R01EY030537 R21EYO19996.
Author information
Authors and Affiliations
Contributions
WVG: obtained funding, conceived the protocol, carried out the protocol, analyzed data, wrote paper. RJW: helped obtain funding and protocol development, data analysis, helped to write paper. AMN: helped to write grant, VEP protocol development, data analysis, write paper. DKS: helped develop protocol, run lab tests, data analysis, write paper. TS: recruited subjects, obtained data (lab), data analysis, helped to write paper. CH: obtained VEP data; conducted data analysis; wrote graph; helped to write paper. VKB: Helped write grant and protocol, obtain data (lab), analyze data, write paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Good, W.V., Wong, R.J., Norcia, A.M. et al. Bilirubin-induced neurotoxicity and visuocortical dysfunction. J Perinatol 43, 240–241 (2023). https://doi.org/10.1038/s41372-022-01417-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-022-01417-2
This article is cited by
-
Insights into the liver-eyes connections, from epidemiological, mechanical studies to clinical translation
Journal of Translational Medicine (2023)